Print Page   |   Report Abuse   |   Sign In   |   Join UPhA
News & Press: Advocacy

The Senate takes a bipartisan swing at drug price reform. Can it connect?

Tuesday, July 23, 2019   (0 Comments)
Posted by: Shannon Glaittli
Share |

by Kyle Blankenship | Jul 23, 2019 5:06pm

With drug price reform at a fever pitch and the 2020 election fast approaching, D.C. is buzzing with flashy proposals to confront pharma.


All of them face big hurdles, though—not least of which is pharma's lobbying prowess. Could a new Senate bill get over the hump?

Two chief members of the Senate Finance Committee—Chairman Chuck Grassley and ranking Democrat Ron Wyden—certainly hope so. They unfurled a bipartisan bill Tuesday aimed at lowering drug prices through a combination of Medicare Part B and D changes and rebates forced on brand-name drugmakers.


Community Search
Sign In


10/29/2020 » 10/30/2020
UPhA 2020 Annual Convention and Exposition